Dana-Farber’s Katherine Janeway, M.D., discusses how reimbursement policies for molecular diagnostics have failed to keep pace with scientific evidence, leaving gaps in the care for pediatric bone ...

Equity gaps in lung cancer molecular testing persist; reflex testing and nurse navigation speed care, while coverage and access barriers stall outcomes Delays in care remain a critical issue. D’Avella ...

Biomarker testing helps doctors create personalized cancer treatments with fewer side effects. Many health insurers deny coverage for this testing, calling it "experimental." Lack of insurance ...

Medicare serves as a crucial healthcare safety net for many Americans, yet it is not without its limitations. In 2026, beneficiaries must be vigilant about the gaps in coverage that could lead to ...

Medicaid and the Children’s Health Insurance Program (CHIP) play critical roles in US child health coverage, but children frequently endure uninsured periods, and recent federal health policy changes ...

The law will mandate insurance coverage for medically necessary PFAS blood tests, aiming to improve public health by aiding ...